Applebee’s owner Dine Brands wants to steal fast-food customers with its deals

Applebee’s owner Dine Brands wants to steal fast-food customers with its deals


Applebee’s and IHOP owner Dine Brands thinks its deals can lure away fast-food customers who have grown frustrated with menu prices.

The company reported first-quarter earnings that fell short of Wall Street’s estimates, and both Applebee’s and IHOP’s same-store sales shrank more than expected. Still, Dine reiterated its full-year outlook and said sales have improved sequentially. Shares of the company were up less than 1% in afternoon trading on Wednesday.

As Applebee’s leans into value with a slate of promotions that includes the return of Dollaritas, Dine Brands CEO John Peyton is confident that the chain can beat out the fast-food chains vying for its customers.

“The Whole Lotta Burger for $9.99 — if you can have our burger for $10, which is great quality, abundant and eat in our restaurant, in our experience, why would you eat a $10 burger out of a paper bag in your car?” he told CNBC.

As consumers pull back their restaurant spending, Applebee’s and IHOP are fighting against a larger group of rivals than usual for a smaller pool of customers. Peyton said full-service restaurants, fast-food chains and even eating at home are all rivals for diners’ dollars.

Low-income consumers visited less frequently and spent more carefully when they did eat out in the first quarter, according to Peyton. Consumers with incomes under $50,000 account for about 40% to 50% of Dine’s customers, he said.

Applebee’s isn’t the only casual-dining chain taking aim at McDonald’s and the rest of the fast-food category. Chili’s, which is owned by Brinker International, recently rolled out an ad campaign that calls out the Big Mac and other fast-food burgers for their prices.

And McDonald’s is certainly feeling the heat. CEO Chris Kempczinski told analysts on the company’s latest earnings call that “everybody’s out there with a value message,” which is why the chain is looking to create a nationwide value menu.

Besides leaning into deals, Applebee’s might also get an edge on the competition from a triad of recent pop-culture moments: a pivotal cameo in the tennis drama film “Challengers,” an Applebee’s-motivated meltdown on “Survivor” and a shout-out from football legend Peyton Manning during Netflix’s roast of his former rival Tom Brady.

Not since Beyonce name-dropped Red Lobster on her hit “Formation” has a casual-dining chain felt so relevant in pop culture.

“It’s top of mind for so many people, and it’s because they’ve grown up with Applebee’s,” Peyton said.



Source

How Domino’s is trying to double its business during a rough patch for big pizza rivals
Business

How Domino’s is trying to double its business during a rough patch for big pizza rivals

In this photo illustration, a Domino’s pizza sits in a take-out box on July 21, 2025 in Miami, Florida. Joe Raedle | Getty Images Domino’s Pizza shares climbed on a Monday after the company posted a better-than-expected quarter and laid out ambitious growth plans. The strong performance came as the pizza chain said it saw […]

Read More
Mortgage rates just dropped below 6%, matching lowest level since 2022
Business

Mortgage rates just dropped below 6%, matching lowest level since 2022

A stock market sell-off had investors rushing to the relative safety of the bond market Monday morning, causing yields to drop and mortgage rates to follow. The average rate on the popular 30-year fixed mortgage fell to 5.99% on Monday, according to Mortgage News Daily, matching its lowest levels since 2022. Last year at this […]

Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can […]

Read More